You are here

Biotech keeps rising as investors worry end is coming

Huge IPOs, valuations for firms that don't yet have a single drug for sale are driving boom
Saturday, March 7, 2015 - 05:50
HANDLE WITH CARE: There is concern that just a few failures in clinical trials could send investors fleeing the booming biotech industry.

New York

BIOTECH'S days of unfettered optimism may be numbered. Since 2011, money has flowed almost non-stop into the industry as investors buy into the promise of new drugs. Signs are increasingly pointing towards an end to the boom.

One key measure of investor pessimism, the